Evaluate Ltd released an episode titled Oncology is now live featuring Ethan Smith and Sofia Petta discussing the commercial picture for oncology.
Public source
Publisher name
Public post
Evaluate Spotlight Ep. 02: Oncology is now live. Watch Ethan Smith and Sofia Petta break down the commercial picture for oncology right now. Here's what the episode cove…
Company
Evaluate Ltd
Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry
- Industry
- Information Services
- Location
- London, GB
- Company size
- 51–200 employees
About Evaluate Ltd
Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. Forecasting Solutions - Ensure precise and efficient forecasting at every stage of your product lifecycle. Our comprehensive suite of forecasting solutions tailored to the pharmaceutical industry, including software, cloud-based platforms, custom-built models, advanced analytics and data. Our forecasting solutions support forecasters through new product planning, launch, and commercialisation. CDMO Intelligence - Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. Consulting and Analytics - Evaluate’s consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio strategy, and corporate strategy-related business questions, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers. Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.
See moreLatest activity
Latest activity from Evaluate Ltd
7 signals
Presence & Recognition
Evaluate Ltd is hosting a session with Kelly Chamberlain, PhD, Partner of Market Intelligence at Norstella at the Junior Ballroom D on Wednesday, September 16, 2026, featuring a live demo of Atlas CI.
Research & Knowledge
Evaluate Ltd published a report highlighting long-term revenue expansion in the orphan drug market.
Presence & Recognition
Evaluate Ltd is heading to Pharma CI USA with a presentation, roundtables, lunch-and-learns, and showcasing Atlas CI, its agentic AI platform built specifically for pharma competitive intelligence.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Citeline
Citeline released a new episode of the Small Biotechs Big Decisions podcast featuring Claire Riches and Carrie Melvin discussing clinical trial execution.
Presence & Recognition
GlobalData Healthcare
GlobalData Healthcare is attending the Pharma CI event at Booth 407 to discuss competitive intelligence and how its intelligence supports priorities.
Presence & Recognition
Decera Clinical Insights
Decera Clinical Insights produced an episode of Oncology Unscripted featuring John Marshall, MD, discussing personalized mRNA vaccines for melanoma and vaccine hesitancy.
Presence & Recognition
Targeted Oncology
Targeted Oncology released a new episode of Targeted Talks featuring gynecologic oncologist Noelle Cloven discussing Gynecologic Cancer Awareness Month and shifting incidence rates in the field.
Presence & Recognition
Hanson Wade